News

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the publication of results from the initial primary analysis of a…
Read More...

Esker Therapeutics, a Foresite Labs-incubated precision medicine company that is reimagining the discovery, development and treatment of autoimmune disorders, launched today with a $70…
Read More...

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, announced the initiation of a…
Read More...

eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, announced a $5.0 million cooperative…
Read More...

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced that its development partner in India, Gennova Biopharmaceuticals, has begun dosing the…
Read More...

Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the completion of…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced an agreement with Gavi, the Vaccine Alliance to supply up to 500 million…
Read More...

The U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and…
Read More...

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced at Vaxart’s key opinion…
Read More...

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings…
Read More...

Revive Therapeutics Ltd. a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it…
Read More...

Hoth Therapeutics, Inc. a patient-focused clinical-stage biopharmaceutical company, announced it intends to pursue development of its HT-KIT mRNA Frame Shifting Therapeutic for multiple…
Read More...

Jacobio Pharmaceuticals has announced  the U.S. Food and Drug Administration (FDA) has approved company's Investigational New Drug (IND) application to develop a KRAS G12C inhibitor.…
Read More...

Thermo Fisher Scientific, the world leader in serving science, today launched the Thermo Scientific E-CFEG, the company's new cold field emission gun and a value-added component for the…
Read More...

Pfizer Inc. announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening…
Read More...

Mesoblast Limited announced the 60 day results from the randomized controlled trial of remestemcel-L in 222 ventilator-dependent COVID-19 patients with moderate/severe acute respiratory…
Read More...

osteolabs GmbH announces the formation of osteolabs UK Limited in Marlow near London. osteolabs UK is a Joint Venture between osteolabs GmbH as majority shareholder and Christopher…
Read More...

Brooklyn ImmunoTherapeutics LLC announced it has acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics…
Read More...

Sirnaomics Biopharmaceuticals (Suzhou) Co. Ltd., a subsidiary of Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against…
Read More...

Catalent, the leading global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and…
Read More...